Ad Hoc Releases

Ad hoc announcements are regulatory announcements which must be published pursuant to an obligation based on German Securities Trading Law (section 15 WpHG). This law requires an issuer of a publicly listed stock to release important news on the company, which is not public knowledge, if the news might have a substantial influence for the share price. This is intended to prevent that news with relevance for the share price are only known to “insiders”, who might use this knowledge to their advantage.

Actual | 2007 | 2006 | 2005 | 2004

12/02/2007	Ad hoc: 2-MorphoSys Financial Guidance 2007 Under Review
12/02/2007	Ad hoc: 1-MorphoSys and Novartis Forge New Strategic Alliance to Establish Innovative Therapeutic Antibody Pipeline
05/03/2007	Ad hoc: MorphoSys Reports Completion of Equity Issue
05/02/2007	Ad hoc: MorphoSys Launches Share Capital Issuance
03/26/2007	Ad hoc: MorphoSys Announces Change in Supervisory Board - Supervisory Board Nominates Walter Blättler as Successor of Andreas Plückthun
07/27/2006	Hugin Ad hoc announcement according to § 15 WpHG: Pure forecast: MorphoSys AG: MorphoSys Raises Financial Guidance for 2006
06/23/2006	Hugin Ad hoc announcement according to § 15 WpHG: Contract: MorphoSys AG: MorphoSys Announces Expansion of Collaboration with Novartis
04/04/2006	Ad hoc: Correction: MorphoSys Reports Completion of Equity Issue
03/29/2006	Ad hoc: MorphoSys Reports Completion of Equity Issue
03/28/2006	Ad hoc: MorphoSys Launches Share Capital Issuance
02/03/2006	Ad hoc: MorphoSys Reports Preliminary Financial Results for 2005
01/12/2006	Ad hoc: MorphoSys Acquires Serotec Group to Strengthen Global Research Antibody Business

• Next page

Subscribe to RSS